Indian health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine referred to as COVAXIN, during a vaccination crusade at all India Institute of medical Sciences (AIIMS) health facility in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi/File picture
BENGALURU, Nov 29 (Reuters) - Indian vaccine maker Bharat Biotech observed on Monday it has resumed export of its COVID-19 shot, Covaxin, and has achieved long-pending orders in November.
Register now at no cost limitless access to reuters.comRegister
< p>Reporting by using Shivani Singh in Bengaluru;enhancing by using Arun KoyyurOur requisites: The Thomson Reuters believe ideas.
0 Comments